Clinical & Pharma

Barcode Errors Pose Fatal Risks, Warns Safety Commissioner
Clinical & Pharma Barcode Errors Pose Fatal Risks, Warns Safety Commissioner

In the United Kingdom, a seemingly minor issue with medicine packaging is spiraling into a major threat to public health, as barcode errors on drug packs put countless lives at risk, leading to potential catastrophic mistakes. These errors, whether due to missing information or incorrect labeling,

Cuban Regime Blames Citizens for Health Crisis Woes
Clinical & Pharma Cuban Regime Blames Citizens for Health Crisis Woes

In the heart of Cuba, a severe epidemiological crisis is unfolding, driven by the relentless spread of the Aedes aegypti mosquito and the alarming rise of arboviral diseases that threaten public health across the nation, setting the stage for a deeper exploration of the tactics and implications

How Will HSRI and AstraZeneca Transform Thai Healthcare?
Clinical & Pharma How Will HSRI and AstraZeneca Transform Thai Healthcare?

In a landmark move for Thailand’s medical landscape, the Health Systems Research Institute (HSRI) and AstraZeneca (Thailand) Co., Ltd. have forged a powerful partnership through a recently signed Memorandum of Understanding (MOU). This collaboration, centered on advancing clinical research within

Endometrial Cancer Risk Models: Insights and Clinical Limits
Clinical & Pharma Endometrial Cancer Risk Models: Insights and Clinical Limits

Endometrial cancer (EC), recognized as the most prevalent gynecologic malignancy in high-income nations, continues to pose a significant public health challenge with its incidence on a steady rise, largely fueled by escalating obesity rates and other modifiable lifestyle factors. The stakes for

Microrobot Revolutionizes Stroke Treatment with Precision
Clinical & Pharma Microrobot Revolutionizes Stroke Treatment with Precision

Imagine a world where a tiny robot, smaller than a grain of sand, can navigate the intricate maze of blood vessels in the human brain to deliver life-saving medication exactly where it’s needed, avoiding the dangerous side effects of traditional treatments. This isn’t science fiction but a

Eli Lilly and NVIDIA Build AI Supercomputer for Drug Discovery
Clinical & Pharma Eli Lilly and NVIDIA Build AI Supercomputer for Drug Discovery

Imagine a world where life-saving medicines are developed at an unprecedented pace, cutting through years of trial and error to deliver treatments to patients in record time, thanks to a groundbreaking partnership between a leading pharmaceutical company and a technology powerhouse. Their

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later